ARCHIVES

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

NCI’s Oral Cancer Chemoprevention Trial On Hold After Fraud Allegations In Norway.

January 27, 2006

Postoperative Chemo Doesn’t Improve Survival, Study Finds

March 28, 2008

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989